Quest Diagnostics to close more laboratories:
This article was originally published in Clinica
The largest clinical laboratory company in the US, Quest Diagnostics, will close or scale down seven labs across the US and shed between 1,250 and 2,500 workers over the next 18 months as it integrates the SmithKline Beecham Clinical Labs acquisition (see Clinica No 846, p 1). The labs which are being downgraded are in markets where the company has duplication. In addition, esoteric testing currently conducted in Van Nuys, California, will move to Quest's Nichols Institute in San Juan Capistrano, California.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.